Cargando…
Research Progress of CXCR4-Targeting Radioligands for Oncologic Imaging
C-X-C motif chemokine receptor 4 (CXCR4) plays a key role in various physiological functions, such as immune processes and disease development, and can influence angiogenesis, proliferation, and distant metastasis in tumors. Recently, several radioligands, including peptides, small molecules, and na...
Autores principales: | Wang, Yanzhi, Gao, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Radiology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462898/ https://www.ncbi.nlm.nih.gov/pubmed/37634642 http://dx.doi.org/10.3348/kjr.2023.0091 |
Ejemplares similares
-
Editorial: Development of selective carbon-11 radioligands for target-based PET molecular imaging in oncology, cardiology and neurology
por: Nerella, Sridhar Goud, et al.
Publicado: (2023) -
Development
of a New Class of CXCR4-Targeting Radioligands
Based on the Endogenous Antagonist EPI-X4 for Oncological Applications
por: Gaonkar, Raghuvir Haridas, et al.
Publicado: (2023) -
CXCR4-targeted theranostics in oncology
por: Buck, Andreas K., et al.
Publicado: (2022) -
Development of PET Radioligands Targeting COX-2 for Colorectal Cancer Staging, a Review of in vitro and Preclinical Imaging Studies
por: Dagallier, Caroline, et al.
Publicado: (2021) -
Commercial and business aspects of alpha radioligand therapeutics
por: Ostuni, Emanuele, et al.
Publicado: (2023)